AMCP Digital Therapeutics Advisory Group
The role of digital therapeutics in preventing, managing, and treating medical conditions continues to evolve, offering the potential for therapeutic benefit. AMCP is committed to leveraging managed care pharmacy to continue to evolve the use of digital therapeutics to improve patient care and outcomes. This group will build upon the recommendations put forth during the previous AMCP Partnership Forums and provide guidance to AMCP in its efforts to establish the leadership role of managed care pharmacy professionals in this area, identify potential partners, and assist in the creation and dissemination of tools and resources to enhance the coverage and utilization of digital therapeutics.
AMCP Collaborate Interest Group:
This online community, available only to AMCP members, will serve as a space to spark conversation, share ideas, and ask questions on all things Digital Therapeutics. Sign up here to join the conversation.
The work of this advisory group is supported by Akili Interactive, Mahana Therapeutics, MetaMe Health, Pear Therapeutics, Pfizer, PhRMA, Otsuka, and Xcenda.